首站-论文投稿智能助手
典型文献
Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
文献摘要:
Hypertension is the leading risk factor for global mortality and morbidity and those with hypertension are more likely to develop severe symptoms in cardiovascular and cerebrovascular system, which is closely related to abnormal renin-angiotensin system and elabela/apelin-apelin receptor (APJ) axis. The elabela/apelin-APJ axis exerts essential roles in regulating blood pressure levels, vascular tone, and cardiovascular dysfunction in hypertension by counterbalancing the action of the angiotensin II/angiotensin II type 1 receptor axis and enhancing the endothelial nitric oxide (NO) synthase/NO signaling. Furthermore, the elabela/apelin-APJ axis demonstrates beneficial effects in cardiovascular physiology and pathophysiology, including angiogenesis, cellular proliferation, fibrosis, apoptosis, oxidative stress, and cardiovascular remodeling and dysfunction during hypertension. More importantly, effects of the elabela/apelin-APJ axis on vascular tone may depend upon blood vessel type or various pathological conditions. Intriguingly, the broad distribution of elabela/apelin and alternative isoforms implicates its distinct functions in diverse cardiac and vascular cells and tissue types. Finally, both loss-of-function and gain-of-function approaches have defined critical roles of the elabela/apelin-APJ axis in reducing the development and severity of hypertensive diseases. Thus, targeting the elabela/apelin-APJ axis has emerged as a pre-warning biomarker and a novel therapeutic approach against progression of hypertension, and an increased understanding of cardiovascular actions of the elabela/apelin-APJ axis will help to develop effective interventions for hypertension. In this review, we focus on the physiology and biochemistry, diverse actions, and underlying mechanisms of the elabela/apelin-APJ axis, highlighting its role in hypertension and hypertensive cardiovascular injury and dysfunction, with a view to provide a prospective strategy for hypertensive disease therapy.
文献关键词:
Elabela;Apelin;APJ;Hypertension;Renin-angiotensin system
作者姓名:
Song Jiawei;Tang Jianqiong;Zhang Zhenzhou;Liu Ying;Zhong Jiuchang
作者机构:
Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China;Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China;Beijing Institute of Respiratory Medicine, Beijing 100020, China
引用格式:
[1]Song Jiawei;Tang Jianqiong;Zhang Zhenzhou;Liu Ying;Zhong Jiuchang-.Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension)[J].中华医学杂志(英文版),2022(09):1019-1026
A类:
elabela,counterbalancing
B类:
Targeting,apelin,receptor,axis,novel,therapeutic,hypertension,Hypertension,leading,risk,global,mortality,morbidity,those,are,likely,severe,symptoms,cardiovascular,cerebrovascular,system,which,closely,related,abnormal,renin,angiotensin,APJ,exerts,essential,roles,regulating,blood,pressure,levels,tone,dysfunction,by,II,enhancing,endothelial,nitric,oxide,synthase,signaling,Furthermore,demonstrates,beneficial,effects,pathophysiology,including,angiogenesis,cellular,proliferation,fibrosis,apoptosis,oxidative,stress,remodeling,during,More,importantly,may,depend,upon,vessel,various,pathological,conditions,Intriguingly,broad,distribution,alternative,isoforms,implicates,its,distinct,functions,diverse,cardiac,cells,tissue,types,Finally,both,loss,approaches,have,defined,critical,reducing,development,severity,hypertensive,diseases,Thus,targeting,emerged,warning,biomarker,against,progression,increased,understanding,actions,will,help,effective,interventions,this,review,we,focus,biochemistry,underlying,mechanisms,highlighting,injury,provide,prospective,strategy,therapy,Elabela,Apelin,Renin
AB值:
0.459782
相似文献
Prenatal inflammation exposure-programmed hypertension exhibits multi-generational inheritance via disrupting DNA methylome
Xiao Guan;Guo-rong Dan;Yao Yang;Yan Ji;Wen-jing Lai;Fang-jie Wang;Meng Meng;Bang-hui Mo;Pei Huang;Ting-ting You;Ya-fei Deng;Liang Song;Wei Guo;Ping Yi;Jian-hua Yu;Yuan Gao;Wei-nian Shou;Bing-bo Chen;You-cai Deng;Xiao-hui Li-Institute of Materia Medica,College of Pharmacy,Army Medical University(Third Military Medical University),Chongqing 400038,China;Department of Obstetrics and Gynecology,The Third Affiliated Hospital of Chongqing Medical University,Chongqing 401120,China;The Ohio State University Comprehensive Cancer Center and the James Cancer Hospital,Columbus,OH 43210,USA;Department of Hematology&Hematopoietic Cell Transplantation,City of Hope National Medical Center and Beckman Research Institute,Duarte,CA 91010,USA;Southwest Hospital/Southwest Eye Hospital,Army Medical University(Third Military Medical University),Chongqing 400038,China;Herman B Wells Center for Pediatric Research,Department of Pediatrics,Indiana University School of Medicine,Indianapolis,IN 46202,USA;Laboratory Animal Center,Army Medical University(Third Military Medical University),Chongqing 400038,China
Therapeutic potential of colchicine in cardiovascular medicine:a pharmacological review
Fan-shun Zhang;Qing-ze He;Chengxue Helena Qin;Peter J.Little;Jian-ping Weng;Suo-wen Xu-Institute of Endocrine and Metabolic Diseases,The First Affiliated Hospital of USTC,Division of Life Science and Medicine,University of Science and Technology of China,Hefei 230001,China;Faculty of Pharmacy and Pharmaceutical Sciences,Monash Institute of Pharmaceutical Sciences,Monash University(Parkville Campus),381 Royal Parade,Parkville 3052 VIC,Australia;Sunshine Coast Health Institute,University of the Sunshine Coast,Birtinya 4575 QLD,Australia;School of Pharmacy,The University of Queensland,Woolloongabba 4102 QLD,Australia;Biomedical Sciences and Health Laboratory of Anhui Province,University of Science&Technology of China,Hefei 230027,China
Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis
Tian-yu Li;Wei Su;Liang-liang Li;Xiao-guang Zhao;Na Yang;Jia-xin Gai;Xin Lv;Jing Zhang;Meng-qin Huang;Qing Zhang;Wei-hang Ji;Xiao-ying Song;Yu-hong Zhou;Xue-lian Li;Hong-li Shan;Hai-hai Liang-Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Zhuhai People's Hospital,Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China;Department of Cardiology,The Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA,Institute for Frontier Medical Technology,Shanghai University of Engineering Science,Shanghai 201620,China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone(2019RU070),Chinese Academy of Medical Sciences,Harbin 150081,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。